Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
09
2026

Is There an Alternative to Mohs Surgery for Non-Melanoma Skin Cancer?

Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…

February
14
2020

Keloid Patient Testimonials

Hear from the patients themselves! These individuals had their keloids treated with SRT and have achieved amazing results.

February
14
2020

Non-Melanoma Skin Cancer Patient Testimonials

Hear from the patients themselves! These individuals had their non-melanoma skin cancer treated with SRT and have achieved amazing results.

February
13
2020

Sensus Healthcare Reports Fourth Quarter and Full Year 2019 Financial Results

Fourth quarter net income up 10-fold to $1.0 million, diluted EPS of $0.06 Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 13, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a…

February
06
2020

Sensus Healthcare to Host Fourth Quarter 2019 Financial Results and Business Update Conference Call on February 13, 2020

BOCA RATON, Fla. , Feb. 06, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry